Insperity stock jumped 5.2% to US$48.68 in the first full session after its Q3 2026 report, a sharp move for a human capital services company that usually trades on slow burn fundamentals rather than daily drama. The headline was blunt. Adjusted EPS swung to a profit of US$0.22 and adjusted EBITDA hit US$31m while worksite employee counts slipped.
Short-term traders are cheering the margin progress. Long-horizon investors are more likely weighing what an 8% uplift in gross profit per worksite employee and a modest 0.04% net margin over the last year might mean for a longer margin rebuild story.
Like the early margin rebuild at Insperity but uneasy about the flat worksite employee trend and thin profitability? Consider screening for human capital and services stocks that pair improving margins with sturdier balance sheets using our list of solid balance sheet and fundamentals stocks (25 results)
Q3 2026 Earnings Summary
-
Revenue (Q3 2026 vs. Q3 2025):US$1,651 million vs. US$1,623 million (up 1.7%)
-
Net Income/Loss (Q3 2026 vs. Q3 2025):loss of US$1 million vs. loss of US$20 million (smaller loss)
-
Basic EPS (Q3 2026 vs. Q3 2025):loss of US$0.02 per share vs. loss of US$0.53 per share (smaller loss per share)
-
Gross Profit per Worksite Employee (Q3 2026 vs. Q3 2025):US$225 per month vs. US$208 per month (up 8%)
If you prefer clean charts to a dense wall of earnings tables and margin tweaks, see Insperity's full visual breakdown, including how analysts are framing the stock today, in the company report for Insperity.
Evaluating Insperity's Margin‑Led Bull Case
The bullish view hinges on Insperity turning specific projects into a durable earnings engine rather than just enjoying a one quarter pop.
"Bullish analysts expect Insperity to turn the HRScale and Workday partnership, healthcare pricing actions, and AI tools into a multi year earnings growth driver that builds on the early recovery in EBITDA and EPS guidance for 2026."
Q3 results give that story some concrete touchpoints. HRScale expenses stayed on plan while adjusted EBITDA reached US$31m and adjusted EPS moved into positive territory. Healthcare actions coincided with an 8% rise in gross profit per worksite employee and 6% higher gross profit even as paid worksite employees fell 1.8%. AI tools are already in market, and management is confident enough to reaffirm a margin focused 2026 plan with tighter worksite employee guidance.
That disagreement has a full argument behind it. → Uncover the higher Fair Value this Narrative argues for .
Insperity bear case: margin repair with thin growth
Bearish investors question whether Insperity is just reshuffling profit rather than rebuilding earnings power.
"HRScale and the Workday partnership are now seen as potentially offsetting softness in the core PEO base, but with limited net benefit to revenue and profit per worksite employee."
Q3 shows some of that concern in the numbers. Average paid worksite employees fell 1.8%, and full year guidance still points to a 1.3% to 1.5% decline. HRScale spend stayed on plan and profit per worksite employee improved 8%, while revenue grew only 1.7%. Progress appears to be driven primarily by margins, with client volume still moving in the wrong direction.
Hunt For Mispriced Earnings Power
Insperity just showed how margin work can progress differently from headcount changes. The real opportunity sits in finding stocks that could be undervalued before the gap closes.
-
Company 1 - 46% below our estimate - uses a growing backlog of tracker and software projects to expand newer storage and inverter offerings into large utility deals.
-
Company 2 - 29% below our estimate - turns a fast expanding customer base and rising revenue per active user into a broader digital banking platform across multiple markets.
-
Company 3 - 48% below our estimate - converts record mechanical and electrical project backlog tied to data centers into high utilization for modular construction and remote monitoring services.
That is three of the list. See every one of the 29 undervalued companies on it →
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Companies discussed in this article include NSP .
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
